ClinicalTrials.gov
public full text
Public Domain
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-A1811 combined with other antitumor therapies in advanced solid tumors. To explore the reasonable dosage of SHR-A1811 combined with other antitumor therapies for advanced solid tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors#896248
- A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors#830062
- SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer#864443
- CP-609,754 in Treating Patients With Advanced Solid Tumors#869888
- A Study of SHR-A1811 in Subjects With Ovarian Cancer#900329
Record · ID 881055
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive